TWIST1 and triple-negative breast carcinoma: Moreover, Hata et al. [18] reported that MUC1-C binds to Twist1, forms an autoregulatory loop with Twist1 and regulates EMT, and targeting MUC1-C could inhibit Twist1, reverses the paclitaxel resistance in triple-negative breast cancer.